Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/26152

Title: A Quality-by-Design approach to risk reduction and optimization for human embryonic stem cell cryopreservation processes
Authors: Mitchell, Peter D.
Ratcliffe, Elizabeth
Hourd, Paul C.
Williams, David J.
Thomas, Robert James
Keywords: Stem cells
Cryopreservation
Quality-by-Design
Issue Date: 2014
Publisher: © Mary Ann Liebert
Citation: MITCHELL, P. ... et al., 2014. A Quality-by-Design approach to risk reduction and optimization for human embryonic stem cell cryopreservation processes. Tissue Engineering. Part C, Methods, 20 (12), pp.941-950.
Abstract: It is well documented that cryopreservation and resuscitation of human embryonic stem cells (hESCs) is complex and ill-defined, and often suffers poor cell recovery and increased levels of undesirable cell differentiation. In this study we have applied Quality-by-Design (QbD) concepts to the critical processes of slow-freeze cryopreservation and resuscitation of hESC colony cultures. Optimized subprocesses were linked together to deliver a controlled complete process. We have demonstrated a rapid, high-throughput, and stable system for measurement of cell adherence and viability as robust markers of in-process and postrecovery cell state. We observed that measurement of adherence and viability of adhered cells at 1h postseeding was predictive of cell proliferative ability up to 96h in this system. Application of factorial design defined the operating spaces for cryopreservation and resuscitation, critically linking the performance of these two processes. Optimization of both processes resulted in enhanced reattachment and post-thaw viability, resulting in substantially greater recovery of cryopreserved, pluripotent cell colonies. This study demonstrates the importance of QbD concepts and tools for rapid, robust, and low-risk process design that can inform manufacturing controls and logistics.
Description: Final publication is available from Mary Ann Liebert, Inc., publishers: https://doi.org/10.1089/ten.tec.2013.0595.
Sponsor: The authors gratefully acknowledge the financial support from Pfizer Neusentis and the EPSRC centre for regenerative medicine.
Version: Accepted for publication
DOI: 10.1089/ten.tec.2013.0595
URI: https://dspace.lboro.ac.uk/2134/26152
Publisher Link: http://dx.doi.org/10.1089/ten.tec.2013.0595
ISSN: 1937-3384
Appears in Collections:Published Articles (Chemical Engineering)

Files associated with this item:

File Description SizeFormat
QbD pub.pdfAccepted version575.1 kBAdobe PDFView/Open

 

SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.